Senior insider sale
CHIEF FINANCIAL OFFICER at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$290.7K
9.05K shares
What this filing means
CLINE CHRISTOPHER R. plans to sell 9.05K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $290.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/14/2026ACC: 0001193125-26-153378
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
9.05K
Shares to sell
$290.7K
Approx. market value
65.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Compensation
4/10/2026
65.00Total acquired65.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/10/2026 | Restricted Stock Unit Vesting Compensation | 65.00 | — |
| Total | 65.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.75K
Market value
$56.2K
2/4/2026
—Completed
Units to sell
7.24K
Market value
$232.6K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
65.00
Market value
$1.9K
4/13/2026
Total
Units
9.05K
Value
$290.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/4/2026 | 1.75K | $56.2K | — | Completed |
2/3/2026 | 7.24K | $232.6K | — | Completed |
| Planned — Approximate Date | ||||
4/13/2026 | 65.00 | $1.9K | NASDAQ | Planned |
| Total | 9.05K | $290.7K | ||